financetom
Business
financetom
/
Business
/
Delta Air, Riyadh Air unveil strategic partnership
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Delta Air, Riyadh Air unveil strategic partnership
Jul 9, 2024 1:09 PM

CHICAGO, July 9 (Reuters) - Riyadh Air has partnered

with U.S. carrier Delta Air Lines ( DAL ) as the Saudi startup

carrier grows its potential network ahead of launching

commercial operations next year, the airlines said on Tuesday.

Riyadh Air, owned by Saudi sovereign wealth fund PIF, will

be a second national airline, based in the capital Riyadh,

alongside existing flag carrier Saudia, based in Jeddah.

Under the agreement, Atlanta-based Delta will serve as

Riyadh Air's exclusive partner in North America, offering its

customers access to hundreds of U.S. destinations.

For Delta's customers, the partnership will open new

destinations in Saudi Arabia, the airlines said. The U.S.

carrier also plans to launch future nonstop service to Riyadh.

Currently, no U.S. airline files to Saudi Arabia.

Delta's first partnership with a Gulf carrier marks a

shift from the last decade when the Atlanta-based airline along

with United and American Airlines ( AAL ) lobbied to

curb competition from Gulf state carriers.

In 2022, however, United unveiled a codeshare agreement

with Dubai's Emirates. American Airlines ( AAL ) has a similar

arrangement with Qatar Airways.

The tie-up between Delta and Riyadh Air envisions

codesharing, which will allow them to sell seats on each other's

flights, but will require regulatory approvals.

In the future, the two carriers plan to expand the

partnership into a joint venture, allowing collaboration on

network planning. Such an arrangement would require immunity

from antitrust laws.

Currently, Delta has joint ventures with Air France-KLM

, British airline Virgin Atlantic, Chile's LATAM

Airlines and Korean Air.

Riyadh Air is trying to build its network through a series

of bilateral partnerships and code shares rather than relying

purely on its own planes, or joining a formal airline alliance.

Last month, it announced partnerships with Singapore

Airlines and Air China.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Syndax Pharmaceuticals Shares Rise After Q2 Results Beat
Syndax Pharmaceuticals Shares Rise After Q2 Results Beat
Aug 5, 2025
02:40 PM EDT, 08/05/2025 (MT Newswires) -- Syndax Pharmaceuticals ( SNDX ) shares were up over 21% in recent Tuesday trading after it posted better-than-expected Q2 financial results in the previous day. Late Monday, the company reported Q2 loss of $0.83 per diluted share, widening from a loss of $0.80 a year earlier. Analysts polled by FactSet expected a loss...
-- BTB REIT Brief: Keeps Sector Perform, But Target Eased To C$3.30 From $3.40 at National Bank As
-- BTB REIT Brief: Keeps Sector Perform, But Target Eased To C$3.30 From $3.40 at National Bank As "Non-Renewals and Lion Electric Lease Renegotiation Weigh on NOI"
Aug 5, 2025
02:36 PM EDT, 08/05/2025 (MT Newswires) -- Price: 3.61, Change: -0.03, Percent Change: -0.82 ...
Esperion Therapeutics Shares Rise After Narrower-Than-Expected Loss, Revenue Beat in Q2
Esperion Therapeutics Shares Rise After Narrower-Than-Expected Loss, Revenue Beat in Q2
Aug 5, 2025
02:38 PM EDT, 08/05/2025 (MT Newswires) -- Esperion Therapeutics ( ESPR ) shares were up 10% in recent trading on Tuesday after the drugmaker reported a narrower-than-expected loss and revenue beat in Q2. The company earlier reported a Q2 net loss of $0.02 per diluted share, narrowing from a loss of $0.33 a year earlier. Analysts polled by FactSet expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved